TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
EMM Life Science AB
Closing information (x1000 NOK)
| Closing information | 2025/08 | 2024/08 | 2023/08 |
| Turnover |
38,616
|
33,250
|
26,609 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
10,651
|
9,829
|
4,236 |
| EBITDA |
10,801
|
9,741
|
2,119 |
| Total assets |
17,533
|
14,013
|
6,429 |
| Current assets |
16,473
|
13,950
|
6,342 |
| Current liabilities |
6,226
|
6,101
|
2,745 |
| Equity capital |
11,307
|
7,911
|
3,680 |
| - share capital |
106
|
103
|
98 |
| Employees (average) |
4
|
4
|
2 |
Financial ratios
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Solvency |
64.5%
|
56.5%
|
57.2% |
| Turnover per employee |
9,654
|
8,312
|
13,304 |
| Profit as a percentage of turnover |
27.6%
|
29.6%
|
15.9% |
| Return on assets (ROA) |
60.7%
|
70.1%
|
65.9% |
| Current ratio |
264.6%
|
228.7%
|
231.0% |
| Return on equity (ROE) |
94.2%
|
124.2%
|
115.1% |
| Change turnover |
4,274
|
5,181
|
-426 |
| Change turnover % |
12%
|
18%
|
-2% |
| Chg. No. of employees |
0
|
2
|
0 |
| Chg. No. of employees % |
0%
|
100%
|
0% |
Total value of public sale
| Fiscal year | 2025/08 | 2024/08 | 2023/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.